Skip to main content
Clinical Trials/KCT0004462
KCT0004462
Completed
未知

A cross-sectional study to evaluate the usefulness of non-invasive hepatic fibrosis marker including Mac-2 binding protein (M2BP) and asialo a1-acid glycoprotein (AsAGP) and insulin resistance marker as a diagnostic indicator of liver fibrosis in the ultrasound-diagnosed fatty liver patients.

Hanyang University Seoul Hospital0 sites2,432 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the digestive system
Sponsor
Hanyang University Seoul Hospital
Enrollment
2432
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Observational Study
Sex
All

Investigators

Sponsor
Hanyang University Seoul Hospital

Eligibility Criteria

Inclusion Criteria

  • We will use medical records from March 1, 2019 to May 31, 2019 for those who performed health check\-ups including abdominal sonography at Hanyang University Medical Center.

Exclusion Criteria

  • 1\) Foreigner
  • 2\) Missing data for skeletal muscle, sonography or alcohol consumption
  • 3\) Viral hepatitis positive or chronic liver disease
  • 4\) Alcohol consumption (\>210 g for men and \>140 g for women
  • 5\) Person who take a medication causing fatty liver such as steoid
  • 6\) No remnant blood sample

Outcomes

Primary Outcomes

Not specified

Similar Trials